Terumo Medical Corporation Executive and Leadership Team

Robert DeRyke, the Executive Officer Division President, Cardiovascular Division, Cardiac and Vascular Company President and Chief Executive Officer, Terumo Cardiovascular Systems Corp. at Terumo Medical Corporation, directs all cardiovascular operations and endovascular therapy initiatives. Overseeing the development of hollow-fiber technology and blood-management systems, the Executive Officer Division President, Cardiovascular Division, Cardiac and Vascular Company President and Chief Executive Officer, Terumo Cardiovascular Systems Corp. ensures alignment with global clinical standards. This leadership role involves managing complex manufacturing processes while expanding market reach across North American and international territories. By optimizing product efficacy and safety, Robert DeRyke directly impacts the company's competitive position in the medical device sector. Through rigorous oversight of the cardiovascular portfolio, the Executive Officer Division President, Cardiovascular Division, Cardiac and Vascular Company President and Chief Executive Officer, Terumo Cardiovascular Systems Corp. secures long-term growth and innovation for the entire organization.

John Pinto, the Chief Financial Officer at Terumo Medical Corporation, manages all fiscal planning, capital allocation, and financial reporting for the organization. Overseeing the financial health of the company, the Chief Financial Officer ensures that investments in hollow-fiber technology and clinical thermometer production remain sustainable and profitable. This leadership role involves collaborating with the Board to maintain fiscal discipline while supporting the expansion of endovascular therapy solutions. By monitoring market trends and operational costs, John Pinto directly impacts the company's ability to scale manufacturing capabilities across the United States. Through precise financial modeling and risk management, the Chief Financial Officer drives the economic stability required to support ongoing research and development. Pinto maintains a focus on long-term value creation, ensuring that every financial decision aligns with the broader mission of delivering high-quality medical products to healthcare providers worldwide.

Keiichi Amatatsu, the President at Terumo Medical Corporation, oversees the strategic direction and operational execution of the company's core business units. Focusing on the expansion of blood-management systems and clinical thermometers, the President drives the company's growth strategy within the competitive medical manufacturing landscape. This leadership role involves coordinating cross-functional teams to ensure that production goals align with market demand and corporate objectives. By fostering a culture of operational excellence, Keiichi Amatatsu directly impacts the company's ability to deliver high-quality medical products to diverse healthcare markets. Through the management of regional operations and strategic partnerships, the President ensures that the organization maintains a strong presence in the medical device industry. Amatatsu prioritizes the development of innovative therapy solutions, ensuring that the company remains at the forefront of medical technology while maintaining the highest standards of manufacturing quality and operational efficiency.

Kota Yamamura, the President at Terumo Medical Corporation, manages the internal scaling and supply chain logistics for the company's diverse medical product portfolio. Focusing on the optimization of manufacturing processes for hollow-fiber technology, the President ensures that production capacity meets the evolving needs of the global healthcare sector. This leadership role involves streamlining operational workflows and enhancing the efficiency of the company's manufacturing facilities. By implementing lean manufacturing principles, Kota Yamamura directly impacts the company's cost structure and product availability. Through the oversight of supply chain resilience and logistics, the President supports the consistent delivery of endovascular therapy solutions to hospitals and clinics. Yamamura maintains a focus on operational scalability, ensuring that the company can adapt to market fluctuations while upholding the quality standards expected of a leading medical manufacturer. This leadership approach drives the company's ability to sustain long-term growth and operational success.

Kalyan Balsubramanian, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology at Terumo Medical Corporation, architects the digital infrastructure supporting global manufacturing and supply chain operations. Overseeing the integration of advanced data systems, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology ensures that blood-management systems and clinical thermometer production lines operate with maximum efficiency. This leadership role involves securing enterprise data while facilitating seamless communication between the Somerset headquarters and international facilities. By implementing scalable cloud solutions and cybersecurity protocols, Kalyan Balsubramanian directly impacts the company's operational agility. Through the modernization of internal IT frameworks, the Chief Information Officer & Chief Information Officer, ) & Vice President, Information Technology supports the rapid deployment of new medical technologies. Balsubramanian maintains a focus on digital transformation, ensuring that information technology remains a core driver of organizational productivity and innovation.

Michael Martinelli, the Senior VP, Medcal Affairs & Chief Medical Officer at Terumo Medical Corporation, directs clinical research, regulatory compliance, and medical safety standards for all product lines. Overseeing the validation of endovascular therapy solutions and hollow-fiber technology, the Senior VP, Medcal Affairs & Chief Medical Officer ensures that every medical product meets rigorous clinical requirements. This leadership role involves collaborating with healthcare professionals to refine product design and improve patient outcomes. By managing the intersection of medical science and manufacturing, Michael Martinelli directly impacts the company's reputation for quality and reliability. Through the oversight of clinical trials and safety protocols, the Senior VP, Medcal Affairs & Chief Medical Officer mitigates risk while fostering innovation in medical device development. Martinelli maintains a commitment to evidence-based practices, ensuring that the company continues to provide safe, effective, and advanced solutions to the global medical community.